CELL THERAPEUTICS INC's ticker is CTIC and the CUSIP is 150934883. A total of 63 filers reported holding CELL THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $23,000 | – | 21,989 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,715,000 | $7,133,000 | 0.86% |
| OXFORD ASSET MANAGEMENT LLP | 1,713,861 | $3,291,000 | 0.08% |
| First Heartland Consultants, Inc. | 74,624 | $143,000 | 0.08% |
| WASHINGTON TRUST Co | 346,616 | $662,000 | 0.05% |
| Geduld E E | 50,000 | $96,000 | 0.05% |
| Tradeworx Inc. | 37,991 | $73,000 | 0.03% |
| Crosspoint Capital Strategies, LLC | 25,000 | $95,000 | 0.03% |
| Jane Street Holding, LLC | 619,120 | $1,183,000 | 0.02% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 132,236 | $253,000 | 0.01% |
| Investors Capital Advisory Services | 17,250 | $32,000 | 0.01% |